CD38-Directed Therapies: Transforming Multiple Myeloma Treatment
CD38-Directed Drugs: A Paradigm Shift in Multiple Myeloma Management CD38-Directed Therapies: Transforming Multiple Myeloma Treatment Multiple Myeloma, a type of blood cancer originating in the plasma cells of the bone marrow, remains a significant challenge in oncology. However, advancements in treatment have introduced CD38-directed therapies a